Candace Westgate, DO
Obstetrics & Gynecology · Indianapolis, INNPI 1669607735
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $79,645 of the $123,251 with a category attached, or 64.6%. 32 manufacturers reported payments, led by Myriad Genetic Laboratories, Inc. at 49.1% of the total. Reporting peaked in 2023 at $64,578 and has fallen 96.4% since, to $2,333 in 2025. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $353.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$61K
- Myriad Women's Health, Inc.$56K
- Bayer$2K
- Applied Medical Resources Corporation$1K
- Astellas Pharma US Inc$485
- Tempus AI, Inc$350
- plus $2K from 26 others
What the payments were for
- Consulting fees$26,77522%
- Speaking & faculty fees$79,64565%
- Travel & lodging$11,74510%
- Food & beverage$4,6524%
- Education$4340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 97 | $60,552 |
| Myriad Women's Health, Inc. | 131 | $56,461 |
| Bayer | 16 | $1,982 |
| Applied Medical Resources Corporation | 3 | $1,098 |
| Astellas Pharma US Inc | 11 | $485 |
| Tempus AI, Inc | 3 | $350 |
| AstraZeneca | 5 | $346 |
| AMAG Pharmaceuticals, Inc. | 17 | $240 |
| Therapeuticsmd, Inc. | 11 | $239 |
| Organon | 10 | $209 |
| AbbVie | 4 | $189 |
| GE HealthCare | 1 | $181 |
| Exact Sciences | 2 | $149 |
| Mayne Pharma Commercial LLC | 8 | $86 |
| GSK | 1 | $79 |
| Myovant Sciences Inc. | 4 | $68 |
| Aspira Women's Health Inc | 3 | $59 |
| Hologic Sales And Service, LLC | 3 | $56 |
| Boehringer Ingelheim | 2 | $52 |
| Pfizer | 2 | $46 |
| Merck | 2 | $45 |
| Baxter Healthcare | 1 | $43 |
| Biogen | 2 | $42 |
| Millicent US Inc | 2 | $40 |
| Shield Therapeutics Inc | 1 | $28 |
| Johnson & Johnson | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Medtronic | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$108,811
- BRACAnalysis$1,750
- Lynkuet$1,600
- GelPOINT V-Path$1,067
- BRAC CDx$1,050
- myChoice CDx$1,050
- GENESIGHT$1,050
- LYNPARZA$225
- XT CDX$216
- Veozah$142
- EGG-AF$134
- Orilissa$118
- PreciseTumor$113
- INTRAROSA$103
How this compares
$123,251 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 225 | $24,246 |
| EstringEstradiol | 21 | $11,075 |
| Estradiol (Twice Weekly)Estradiol | 48 | $6,439 |
| YuvafemEstradiol | 37 | $5,850 |
| DottiEstradiol | 25 | $2,640 |
| ProgesteroneProgesterone, Micronized | 63 | $1,911 |
| Raloxifene Hcl | 18 | $532 |
| ValacyclovirValacyclovir Hcl | 17 | $453 |
| Metronidazole | 13 | $360 |
| Alendronate Sodium | 22 | $175 |
| Triamcinolone Acetonide | 12 | $43 |
| Ibuprofen | 12 | $41 |
| Trazodone Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEstring | $46 | $11,07521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.
Other obstetrics & gynecology in Indianapolis
- Osman ChaudhryIndianapolis$10K
- Rachel LelandIndianapolis$9K
- Colleen McDermottIndianapolis$8K
- Maryann ChimhandaIndianapolis$7K
- Ashley ScottFort Wayne$124K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.